The FDA issued a new warning about some of the popular diabetes drugs being used for weight loss after the agency “received adverse event reports after patients used compounded semaglutide.” That’s the generic name for medications like Ozempic and Wegovy. New York endocrinologist Dr. Florence Comite joins CBS News to discuss the risks of taking off-brand versions.
Source: CBS Minnesota
The risks of taking off-brand Ozempic for weight loss, according to a doctor
Published in Fifty Lakes
More from Fifty LakesMore posts in Fifty Lakes »
- Hegseth deflects direct involvement in Sept. 2 boat strike orders, praises Admiral Bradley
- Trump says "affordability" is con job during Cabinet meeting, Hegseth touts lethal boat strikes
- Hegseth defends deadly boat strikes near Venezuela during Cabinet meeting: "We've only just begun"
- Watch Live: Trump holds final Cabinet meeting of the year at White House
- 11/24: Face the Nation
Be First to Comment